Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Boku Inc. Stuart Neal on Soaring Revenue, Explosive Wallet Growth, and What’s Fueling 2025’s Surge (Video)
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Boku Inc. Stuart Neal on Soaring Revenue, Explosive Wallet Growth, and What’s Fueling 2025’s Surge (Video)
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
ICU Medical Inc. (ICUI) Stock Analysis: Exploring a Potential 53% Upside with Strong Buy Ratings 22 July 2025
Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 240% Upside Potential for Investors 22 July 2025
Ardent Health, Inc. (ARDT) Stock Analysis: Exploring an 84.81% Potential Upside for Investors 22 July 2025
Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 60% Potential Upside with Strong Buy Ratings 22 July 2025
Arrowhead Pharmaceuticals (ARWR): Unveiling a 199% Upside Potential with a Robust Product Pipeline 22 July 2025
Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 77.55% Potential Upside in the Healthcare Diagnostics Space 22 July 2025
Privia Health Group, Inc. (PRVA) Stock Analysis: A 50% Upside Potential with Strong Buy Ratings 22 July 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Look at its Promising 32% Upside Potential 22 July 2025
MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unveiling a 46% Upside Potential in the Biotech Space 22 July 2025
Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Uncovering a 75% Upside Potential in Biotech 22 July 2025
LivaNova PLC (LIVN): Investor Outlook on a Medical Device Giant with 44% Upside Potential 22 July 2025
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector 22 July 2025
SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating Growth in Rare Diseases and Cancer Treatment 22 July 2025
Alignment Healthcare, Inc. (ALHC) Stock Analysis: Unpacking 45.78% Potential Upside in the Healthcare Sector 22 July 2025
ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: A Potential 28.98% Upside as CNS Drug Portfolio Expands 22 July 2025
Boku Inc. Stuart Neal on Soaring Revenue, Explosive Wallet Growth, and What’s Fueling 2025’s Surge (Video) 1 October 2025
Manx Financial Group Record Profits, Fintech Deals, and a Lending Surge Fuel 2025 Growth (Video) 30 September 2025
Cizzle Biotechnology US Rollout Begins as Lung Cancer Test Moves from Lab to Clinic (Video) 30 September 2025
Avingtrans Plc Record Results, New Nuclear Wins and the Power of AI-Driven Demand (Video) 25 September 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Berkeley Group posts £254 million profit and maintains strong cash position in interim results 10 December 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
